This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ORTHOWORLD(R) Announces FDA Official To Serve As Panelist At Orthopaedic Manufacturing & Technology Exposition And Conference (OMTEC(R))

CHAGRIN FALLS, Ohio, April 12, 2013 /PRNewswire/ -- ORTHOWORLD, Inc., leading producer of strategic intelligence for the orthopaedic industry, announced its education curriculum for OMTEC 2013, to be held June 12-13 in Chicago.

OMTEC's keynote panel discussion, The State and Future of U.S. FDA, brings together regulatory experts to talk about current and future FDA decisions that are impacting all stakeholders within the supply chain, including 510(k) clearance and supplier compliance. Dialogue is aimed at providing high-level actionable advice for orthopaedic device companies, contract manufacturers, investors and others.

A complementary lineup of lectures, including How to Design and Execute a Clinical Trial, Unique Device Identification Compliance, Trends in FDA Recalls and Tools for Qualifying Suppliers, delivers further insights and recommendations to orthopaedic industry professionals amidst intense regulatory scrutiny.

"OMTEC consistently attracts industry achievers," explains April Bright, General Manager of ORTHOWORLD. "Each year I'm amazed, impressed and humbled by OMTEC's supporters. They understand that investments in education and personal relationships yield return, especially in the absence of regulatory, political or economic certainty. Attendees and exhibitors genuinely care about the livelihood of one another and the continued health of the specialty of orthopaedics. OMTEC is proud to be the place they gather to raise the performance bar another notch."

The first and predominant conference of its kind, OMTEC is expected to host nearly 1,000 industry professionals from across the globe. The event website,, provides complete details on the acclaimed educational lineup, exhibitor listings and confirmed registrants.

ABOUT ORTHOWORLD Founded in 1992, ORTHOWORLD is a highly specialized publishing firm offering strategic intelligence, integrated advertising and educational conferences exclusively to the global orthopaedic market. Its singular mission is helping orthopaedic companies and individuals improve their performance.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs